ACE2 and COVID-19: ACE2 and TMPRSS2 were shown to be the key mediators of SARS-CoV-2 viral entry early in the COVID-19 pandemic, but which cells of the upper airway tract express them and mechanisms governing their expression in the lung were not defined (3, 4).